Godavari Biorefineries showed strong FY26 results!

Total Income hit ₹2,000.2 Cr (+6.0% YoY) and EBITDA jumped 15.8% to ₹139.3 Cr.

Importantly, the company turned profitable with a ₹3.5 Cr Profit After Tax.

Bio-Based Chemicals revenue rose 6.6% to ₹578 Cr, with specialty products now 61% of segment revenue.

Ethanol revenue climbed 12.6% to ₹658.6 Cr.

Growth drivers include a focus on high-margin bio-based specialty chemicals, a new 200 KLPD grain/maize distillery coming online by June 2026 for ethanol, and global partnerships expanding green chemistry.

Recent wins: awards for safety & sustainability, global showcases, and big strides in drug discovery.

This includes a Japanese patent for antiviral therapy and a Q2 FY26 CDSCO filing target for a Triple-Negative Breast Cancer treatment.

Management is bullish, positioning GBL at the forefront of the global shift to sustainable, bio-based solutions, backed by strategic investments and a commitment to regenerative agriculture.